Invention Grant
- Patent Title: Pyrrolidine GPR40 modulators
-
Application No.: US15308459Application Date: 2015-05-06
-
Publication No.: US10301260B2Publication Date: 2019-05-28
- Inventor: Xiang-Yang Ye , Bruce A. Ellsworth , Elizabeth A. Jurica
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Jing G. Sun
- International Application: PCT/US2015/029459 WO 20150506
- International Announcement: WO2015/171757 WO 20151112
- Main IPC: C07D207/08
- IPC: C07D207/08 ; C07D401/04 ; C07D413/04 ; C07D207/12 ; C07D207/14 ; C07D207/16 ; A61K45/06 ; A61K31/40 ; A61K31/422 ; A61K31/4439

Abstract:
The present invention provides compounds of Formula (I): or a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a polymorph, or a solvate thereof, wherein all of the variables are as defined herein. These compounds are GPR40 G protein-coupled receptor modulators which may be used as medicaments.
Public/Granted literature
- US20170081282A1 PYRROLIDINE GPR40 MODULATORS Public/Granted day:2017-03-23
Information query